Abstract: Apparatuses and methods for non-invasively detecting and classifying transcranial electrical signals are disclosed herein. In an embodiment, system for detecting and interpreting transcranial electrical signals includes: a headset including a plurality of electrodes arranged for detection of the user's transcranial electrical signals; a display configured to display information to the user while the user wears the headset; and a control unit programmed to: (i) receive data relating to the transcranial electrical signals detected by the electrodes of the headset; (ii) create a data matrix with the received data; (iii) convert the data matrix into one or more user values; (iv) define a user output state based on the one or more user values; and (iv) cause alteration of an aspect of the display based on the user output state.

Abstract: A nasal device for filtering air breathed into a user's nose is disclosed herein. In an embodiment, a nasal device includes a body sized and shaped to be secured to at least one of a user's nostrils, and a filter positioned on the body so as to be located over at least one of the user's nasal passages when the body is secured to the user's at least one nostril, wherein the filter filters air breathed into the user's at least one nasal passage when the body is secured to the user's at least one nostril.

Abstract: A nasal device for filtering air breathed into a user's nose is disclosed herein. In an embodiment, a nasal device includes a body sized and shaped to be secured to at least one of a user's nostrils, and a filter positioned on the body so as to be located over at least one of the user's nasal passages when the body is secured to the user's at least one nostril, wherein the filter filters air breathed into the user's at least one nasal passage when the body is secured to the user's at least one nostril.

Abstract: Apparatuses and methods for non-invasively detecting and classifying transcranial electrical signals are disclosed herein. In an embodiment, system for detecting and interpreting transcranial electrical signals includes: a headset including a plurality of electrodes arranged for detection of the user's transcranial electrical signals; a display configured to display information to the user while the user wears the headset; and a control unit programmed to: (i) receive data relating to the transcranial electrical signals detected by the electrodes of the headset; (ii) create a data matrix with the received data; (iii) convert the data matrix into one or more user values; (iv) define a user output state based on the one or more user values; and (iv) cause alteration of an aspect of the display based on the user output state.

Abstract: In an embodiment, a surgical implant includes a body extending from a distal end to a proximal end, the body having a first section proximal to the distal end and a second section between the first section and the proximal end, a needle attachment member located at the distal end of the body, the needle attachment member configured to attach to a needle for insertion of the surgical implant into a patient's tissue, a plurality of first barbs located on the first section of the body, the first barbs pointed towards the proximal end of the body, and a plurality of second barbs located on the second section of the body, the second barbs pointed towards the distal end of the body, wherein the second barbs are configured to be folded inwardly for insertion of the surgical implant into the patient's tissue by the needle.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitve proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: In an embodiment, a surgical implant includes a body extending from a distal end to a proximal end, the body having a first section proximal to the distal end and a second section between the first section and the proximal end, a needle attachment member located at the distal end of the body, the needle attachment member configured to attach to a needle for insertion of the surgical implant into a patient's tissue, a plurality of first barbs located on the first section of the body, the first barbs pointed towards the proximal end of the body, and a plurality of second barbs located on the second section of the body, the second barbs pointed towards the distal end of the body, wherein the second barbs are configured to be folded inwardly for insertion of the surgical implant into the patient's tissue by the needle.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Methods and apparatuses for lifting, suspending and stiffening a patient's tissue are disclosed. In an embodiment, a surgical implant includes a body having a distal end and a proximal end, a needle attachment member located at the distal end of the body, a plurality of first barbs located on the body proximal to the distal end, the plurality of first barbs pointed towards the proximal end of the body, and a plurality of second barbs located on the body between the plurality of first barbs and the proximal end, the plurality of second barbs pointed towards the distal end of the body.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.